Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus: Complete Statistical AnalysisIndependent statistical analysis of Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Duration of Analgesia After Popliteal Fossa Nerve Blockade: Effects of Dexamethasone and Buprenorphine: Complete Statistical AnalysisIndependent statistical analysis of Duration of Analgesia After Popliteal Fossa Nerve Blockade: Effects of Dexamethasone and Buprenorphine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Duration of Benefit for OnabotulinumtoxinA in Treatment of Chronic Migraine: Complete Statistical AnalysisIndependent statistical analysis of Duration of Benefit for OnabotulinumtoxinA in Treatment of Chronic Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02037425).
- Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose: Complete Statistical AnalysisIndependent statistical analysis of Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH: Complete Statistical AnalysisIndependent statistical analysis of Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01753830).
- Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and IIIA Non-small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and IIIA Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC: Complete Statistical AnalysisIndependent statistical analysis of Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Durvalumab and Tremelimumab for Pediatric Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Durvalumab and Tremelimumab for Pediatric Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03837899).
- Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH): Complete Statistical AnalysisIndependent statistical analysis of Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia: Complete Statistical AnalysisIndependent statistical analysis of Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01231607).
- DVIndependent statistical analysis of Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021).: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03242590).
- DyeVert™ Plus Contrast Reduction System Multicenter Observational Study: Complete Statistical AnalysisIndependent statistical analysis of DyeVert™ Plus Contrast Reduction System Multicenter Observational Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03715452).
- DYNAMOIndependent statistical analysis of A Study of Duvelisib in Participants With Refractory Indolent Non-Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DysmenorrheaIndependent statistical analysis of Continuous Administration of Oral Contraceptive, Primary Dysmenorrhea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00517556).
- Dysport® Pediatric Lower Limb Spasticity Follow-on Study: Complete Statistical AnalysisIndependent statistical analysis of Dysport® Pediatric Lower Limb Spasticity Follow-on Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01251380).
- DYSTANCE 51Independent statistical analysis of Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- E-CAREIndependent statistical analysis of Long-term Effectiveness of Abdominal Sacrocolpopexy for the Treatment of Pelvic Organ Prolapse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- E-Cigarette Effects on Markers of Cardiovascular and Pulmonary Disease: Complete Statistical AnalysisIndependent statistical analysis of E-Cigarette Effects on Markers of Cardiovascular and Pulmonary Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03863509).
- e-DomSantéIndependent statistical analysis of Evaluation of Efficiency in Cancerology of New Technologies as Telemedicine and Conected Objects (e-DomSanté): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- e-HealthIndependent statistical analysis of Scaling Up: A Multi-Site Trial of e-SBI for Alcohol Use in Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- E-MomsIndependent statistical analysis of A Personalized Telehealth Intervention for Health and Weight Loss in Postpartum Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- E-SCAR DMDIndependent statistical analysis of Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01521546).
- E-TIPSIndependent statistical analysis of Telehealth Pain Self-Management for Employed Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04248725).
- E-Visit for COPD and Smoking Cessation: Complete Statistical AnalysisIndependent statistical analysis of E-Visit for COPD and Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04155073).
- E2SERTIndependent statistical analysis of Postpartum Depression: Transdermal Estradiol Versus Sertraline: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00744328).
- E3 Breast Cancer Taxotere Combination: Complete Statistical AnalysisIndependent statistical analysis of E3 Breast Cancer Taxotere Combination: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00494481).
- E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer: Complete Statistical AnalysisIndependent statistical analysis of E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck: primary endpoint results, effect estimate with confidence…
- E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes: Complete Statistical AnalysisIndependent statistical analysis of E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- E7080 (Lenvatinib) in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV Melanoma: Complete Statistical AnalysisIndependent statistical analysis of E7080 (Lenvatinib) in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size…
- EADCRAVIndependent statistical analysis of Enabling Advance Directive Completion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01746368).
- EAER21Independent statistical analysis of Validation of Indiana's Early Evaluation Hub System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06586788).
- EAGeRIndependent statistical analysis of The Effects of Aspirin in Gestation and Reproduction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00467363).
- EAGLEIndependent statistical analysis of Study of MEDI4736 Monotherapy and in Combination With Tremelimumab Versus Standard of Care Therapy in Patients With Head and Neck Cancer: primary endpoint results, effect estimate with confidence…
- EAGLESIndependent statistical analysis of Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders: primary endpoint results, effect estimate…
- EAISEIndependent statistical analysis of A Safety and Efficacy Study of Intravenous (IV) Elezanumab Assessing Change in Neurologic Function in Adult Participants With Acute Ischemic Stroke: primary endpoint results, effect estimate with confidence…
- Early Airway Response to Allergen in Asthmatics (MK-0000-176): Complete Statistical AnalysisIndependent statistical analysis of Early Airway Response to Allergen in Asthmatics (MK-0000-176): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01061333).
- Early Antibiotics After Aspiration in ICU Patients: Complete Statistical AnalysisIndependent statistical analysis of Early Antibiotics After Aspiration in ICU Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05079620).
- Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis: Complete Statistical AnalysisIndependent statistical analysis of Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis: primary endpoint results, effect estimate…
- Early Diuresis Following Colorectal Surgery: Complete Statistical AnalysisIndependent statistical analysis of Early Diuresis Following Colorectal Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02351934).
- Early Feasibility Study Using IOPCL MAG to Improve Near Vision in ARMD Subjects: Complete Statistical AnalysisIndependent statistical analysis of Early Feasibility Study Using IOPCL MAG to Improve Near Vision in ARMD Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Early Increase in Blood Flow (EIBS) in the Duodenum in Patients With Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Early Increase in Blood Flow (EIBS) in the Duodenum in Patients With Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Early Insulin and Development of ARDS: Complete Statistical AnalysisIndependent statistical analysis of Early Insulin and Development of ARDS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00605696).
- Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- EARNESTIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- EASEIndependent statistical analysis of Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EASE SBS 1Independent statistical analysis of Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- EASYIndependent statistical analysis of Effects of Ergocalciferol on Erythropoetin Stimulating Agent Dose: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01263028).
- EasyMixIndependent statistical analysis of Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type…